Rothenberg Mace bought TNGX
June 5, 2026 · Form 4 insider transaction
Rothenberg Mace bought 4,000 shares of Tango Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,000
Price
$0.00
Total value
N/A
InsiderRothenberg Mace
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 5, 2026
Filing dateJune 8, 2026
Shares owned after41,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in their entirety on the earlier of: (i) June 5, 2027 and (ii) the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.